Fusion event
HBV-EYA2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TAGAAAACTTCCTATTAACAGGCCTATTGATTGGAAAGTATGTCAACGAATTGTGGGTCTTTTGGGTTTTGCTGCCCCTTTTACACAATGTGGTTATCCT| |GCGTTGATGCCTTTGTATGCATGTATTCAATCTAAGCAGGCTTTCACTTTCTCGCCAACTTACAAGGCCTTTCTGTGTAAACAATACCTGAACCTTTACC
End
45795514/47166872 (Hg38)
miRNAs that regulate target gene
Nearest miRNA
hsa-mir-103a-2/Upstream/1461692; hsa-mir-1-1/Downstream/95;
Upstream sequence
cagttatcaggtccatttatcagtcaggcctctggggttcatgagggtcatgcccctcactcaaggtcacacactgggaagcggttggatccaggatcca
Downstream sequence
ggcccaggcagtcagattccagagcctgcaccctgaaccagtaCCGCAGGGGCTGGCACCCCCGCACATTTTTTGCCCCATCAACATATTATCATGTCAC
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.